| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.088 | 0.004 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.44 | 0.006 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.43 | 0.01 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.36 | 0.02 |